试验雷达 AI | ||
|---|---|---|
临床试验 NCT07158047 针对Obesity (Disorder)目前招募中。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。 | ||
一个试验符合筛选条件
卡片视图
返回搜索
俄勒冈大学Repeated Far Infrared Sauna Bathing in Adults With Obesity 20
临床试验详情主要以英语提供。然而，试验雷达 AI可以提供帮助！只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT07158047是一项针对Obesity (Disorder)的干预性研究试验，目前试验状态为招募中。试验始于2022年3月7日，计划招募20名患者。该研究由俄勒冈大学主导，预计于2026年7月31日完成。试验数据来源于ClinicalTrials.gov，最后更新时间为2026年3月4日。
简要概括
This is a clinical trial to determine if 30 sessions of far infrared sauna bathing can improve cardiovascular and metabolic function in adults with obesity.
详细描述
Obesity can increase the risk for cardiovascular and metabolic diseases. Lifestyle interventions are needed to reduce this risk. Far infrared saunas are one form of heat therapy that may help reduce these risks, however, there is limited research within a population with obesity. It is hypothesized that repeated far infrared sauna bathing will improve cardiovascular and metabolic function in adults with obesity.
官方标题
Targeting Hypertension and Insulin Resistance With Heat Therapy
疾病
Obesity (Disorder)出版物
关于此临床试验发表的科学文章和研究论文：其他研究标识符
- 07312020.034
- 19TPA34890033 (其他拨款/资助编号) (American Heart Association)
NCT编号
实际开始日期
2022-03-07
最近更新发布
2026-03-04
预计完成日期
2026-07-31
计划入组人数
20
研究类型
干预性研究
试验分期 (阶段)
不适用
试验状态
招募中
关键词
heat therapy
insulin resistance
arterial stiffness
blood pressure
obesity
sauna
vascular health
cardiovascular
metabolic function
insulin resistance
arterial stiffness
blood pressure
obesity
sauna
vascular health
cardiovascular
metabolic function
主要目的
基础研究
分配方式
随机
干预模型
平行
盲法
无（开放性试验）
试验组/干预措施
| 参与者组/试验组 | 干预措施/治疗方法 |
|---|---|
实验性Heat therapy Group will undergo 30 sessions of heat therapy over approximately 10 weeks. Sessions will require participants to sit in a far infrared sauna for up to 45 min for 3 to 4 times per week. | 热疗 30 sessions of far infrared sauna bathing (45-60C) for up to 45 min |
无干预Time control group No participation in sauna bathing. Maintain lifestyle habits for approximately 10 weeks. | 不适用 |
主要终点
次要终点
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Blood pressure change | Change in systolic and diastolic blood pressures after 30 sessions of Intervention | 10 weeks |
Blood glucose | Change in plasma glucose levels after Intervention | 10 weeks |
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Arterial stiffness reduction | Change in Carotid-femoral Pulse Wave Velocity (m/s) after Intervention | 10 weeks |
Serum insulin | Change in serum insulin levels after Intervention | 10 weeks |
参与助手
资格标准
适龄参与研究
成人
最低年龄要求
18 Years
适龄性别
全部
- BMI between 30-45 kg/m2
- Diagnosed diabetes
- Greater than stage 2 hypertension
- Coagulopathies
- Allergies to lidocaine
- Medications affecting blood pressure
- Blood clotting, and blood sugars
- Smoker
- Pregnant
- Desiring to become pregnant in the near future
- Breastfeeding
- BMI less than 30
- BMI greater than 45 kg/m2
- Exercising > 120 min/week
- Taking medications (other than hormone contraceptives)
- Not willing to stop taking medications (other than hormone contraceptives) for 24 hours before testing days
俄勒冈大学研究责任方
Christopher T Minson, PhD, 主要研究者, Professor, University of Oregon
研究中心联系人
联系人: Christopher T Minson, PhD, 541-346-7583, [email protected]
联系人: John R Halliwill, PhD, 541-346-7591, [email protected]
1 位于 1 个国家/地区的研究中心
Oregon
University of Oregon, Eugene, Oregon, 97401, United States
Christopher T Minson, PhD, 联系人, 5413467583, [email protected]
John R Halliwill, PhD, 联系人, 5413467591, [email protected]
Christopher T Minson, PhD, 主要研究者
招募中